These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination. Kim S; Lee EK; Sohn E J Korean Med Sci; 2023 Feb; 38(8):e57. PubMed ID: 36852853 [TBL] [Abstract][Full Text] [Related]
10. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. Wendt T; Eidner T; Bräunig E; Hein G Eur J Med Res; 1999 Oct; 4(10):442-8. PubMed ID: 10527958 [TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review. Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435 [TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. RMC Trial Group Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. Hughes RA; Swan AV; van Doorn PA Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. Hughes RA; Swan AV; van Doorn PA Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467 [TBL] [Abstract][Full Text] [Related]
15. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies. Dalakas MC J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621 [TBL] [Abstract][Full Text] [Related]
16. A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. Heckmann JM; Rawoot A; Bateman K; Renison R; Badri M BMC Neurol; 2011 Aug; 11():97. PubMed ID: 21819556 [TBL] [Abstract][Full Text] [Related]
17. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
18. A Severe Form of M - protein Negative Distal Acquired Demyelinating Symmetric Neuropathy. Ong TL; Goh KJ; Shahrizaila N; Wong KT; Tan CY Neurol India; 2019; 67(6):1532-1535. PubMed ID: 31857554 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Suanprasert N; Hanchaiphiboolkul S J Med Assoc Thai; 2017 Mar; 100(3):262-9. PubMed ID: 29911781 [TBL] [Abstract][Full Text] [Related]
20. Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient. Díaz-Manera J; Rojas-García R; Gallardo E; Illa I Muscle Nerve; 2009 Mar; 39(3):386-8. PubMed ID: 19208395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]